UNSPSC 51191559: Mersalyl

This classification denotes a diuretic with the molecular formula C13H15HgNO5.Na.HO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5X1IO031V8, chemically known as mercury, 3-(alpha-carboxy-o-anisamido)-2-methoxypropyl hydroxy-, monosodium salt but generally known as mersalyl, which bears US NIH Compound Identifier 10293. European Medicines Agency schedules Mersalyl in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08779MIG. The term MERSALYL is an International Non-Proprietary Name.

UNSPSC 51191559 Mersalyl is a Commodity code that in practice encompasses chemical supply products for municipal water treatment and healthcare facility operations, as demonstrated by recent state and local solicitations spanning pharmaceutical and chemical commodities. State and local governments use this code to procure generic pharmaceuticals, over-the-counter products, and water treatment chemicals including sodium bisulfite for pollution control facilities. The issuing bodies include municipal water utilities, state cooperative purchasing alliances, and multistate procurement consortia. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, represents a significant buyer in this space, coordinating procurement across participating state and local government facilities. Individual cities such as Meriden, Connecticut also solicit independently for specific chemical commodities.

Recent activity spans multiple states and procurement formats. The City of Meriden posted an IFB for sodium bisulfite chemical supply (solicitation B027-15) due July 29, 2026, specifying delivery to its Water Pollution Control Facility with unit-cost-based pricing evaluation and performance and payment bonds required. MMCAP issued an RFP (S1070000015802) on January 20, 2026 with response due March 26, 2026 to establish multiple contracts for generic pharmaceuticals and OTC products across Minnesota, Oregon, and other participating states, requiring vendors to meet current Good Manufacturing Practices certification, Drug Supply Chain Security Act compliance, and maintain relationships with authorized wholesalers. The MMCAP procurement emphasizes price competitiveness (75 percent of evaluation weight) and administrative compliance with electronic data interchange capability. Contractors pursuing both opportunities face significant insurance requirements, with the MMCAP procurement requiring $5 million general liability coverage and the municipal opportunity requiring $1 million to $2 million General Liability with Connecticut-approved carriers.